Given the growing importance of FAM46C as a broad tumour suppressor, several groups have attempted to define the synergistic effects between FAM46C expression or inactivation and cancer cell sensitivity to anticancer drugs, sometimes obtaining contradictory results. The gene discussed is TENT5C; the disease is neoplasm.